Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 27 studies | 47% ± 24% | |
astrocyte | 21 studies | 53% ± 22% | |
pericyte | 20 studies | 58% ± 21% | |
connective tissue cell | 17 studies | 43% ± 22% | |
oligodendrocyte precursor cell | 16 studies | 58% ± 17% | |
smooth muscle cell | 16 studies | 49% ± 21% | |
oligodendrocyte | 15 studies | 38% ± 14% | |
endothelial cell | 9 studies | 42% ± 15% | |
neuron | 7 studies | 36% ± 9% | |
basal cell | 6 studies | 33% ± 14% | |
GABAergic neuron | 6 studies | 33% ± 9% | |
mesothelial cell | 6 studies | 55% ± 16% | |
retina horizontal cell | 6 studies | 77% ± 13% | |
amacrine cell | 6 studies | 38% ± 14% | |
myofibroblast cell | 5 studies | 60% ± 20% | |
epithelial cell | 5 studies | 27% ± 4% | |
interneuron | 5 studies | 33% ± 7% | |
Mueller cell | 5 studies | 55% ± 22% | |
microglial cell | 4 studies | 49% ± 29% | |
glutamatergic neuron | 4 studies | 29% ± 12% | |
progenitor cell | 3 studies | 38% ± 21% | |
abnormal cell | 3 studies | 46% ± 21% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 59% ± 5% | |
glial cell | 3 studies | 55% ± 26% | |
GABAergic amacrine cell | 3 studies | 40% ± 4% | |
glycinergic amacrine cell | 3 studies | 27% ± 6% | |
extravillous trophoblast | 3 studies | 59% ± 9% | |
placental villous trophoblast | 3 studies | 39% ± 13% | |
ciliated cell | 3 studies | 20% ± 5% | |
myoepithelial cell | 3 studies | 61% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 9275.07 | 2641 / 2642 | 100% | 1199.20 | 702 / 705 |
prostate | 98% | 6170.30 | 241 / 245 | 80% | 151.84 | 402 / 502 |
uterus | 96% | 4424.55 | 163 / 170 | 44% | 133.85 | 204 / 459 |
bladder | 71% | 1408.76 | 15 / 21 | 32% | 94.48 | 161 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 157.37 | 1 / 1 |
lung | 58% | 1053.59 | 333 / 578 | 28% | 41.14 | 324 / 1155 |
thymus | 74% | 1431.77 | 482 / 653 | 11% | 28.35 | 69 / 605 |
kidney | 53% | 1372.37 | 47 / 89 | 32% | 42.54 | 285 / 901 |
breast | 52% | 2447.21 | 238 / 459 | 32% | 61.31 | 353 / 1118 |
esophagus | 60% | 1878.22 | 868 / 1445 | 23% | 23.74 | 42 / 183 |
heart | 77% | 2527.80 | 661 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 71% | 113.66 | 32 / 45 |
ovary | 22% | 280.71 | 39 / 180 | 46% | 68.51 | 199 / 430 |
intestine | 64% | 1488.85 | 614 / 966 | 3% | 2.27 | 14 / 527 |
adrenal gland | 6% | 200.29 | 16 / 258 | 60% | 273.24 | 138 / 230 |
spleen | 52% | 868.45 | 126 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 52% | 1008.64 | 695 / 1335 | 0% | 0 | 0 / 0 |
stomach | 29% | 548.28 | 103 / 359 | 6% | 5.11 | 16 / 286 |
adipose | 33% | 849.33 | 399 / 1204 | 0% | 0 | 0 / 0 |
skin | 14% | 192.68 | 248 / 1809 | 14% | 110.31 | 64 / 472 |
pancreas | 0% | 2.68 | 1 / 328 | 15% | 19.98 | 26 / 178 |
eye | 0% | 0 | 0 / 0 | 5% | 5.33 | 4 / 80 |
liver | 1% | 9.39 | 2 / 226 | 2% | 4.09 | 7 / 406 |
muscle | 0% | 4.05 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903706 | Biological process | regulation of hemopoiesis |
GO_0044849 | Biological process | estrous cycle |
GO_0031641 | Biological process | regulation of myelination |
GO_0010996 | Biological process | response to auditory stimulus |
GO_0051781 | Biological process | positive regulation of cell division |
GO_2000347 | Biological process | positive regulation of hepatocyte proliferation |
GO_0043932 | Biological process | ossification involved in bone remodeling |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0007612 | Biological process | learning |
GO_0046697 | Biological process | decidualization |
GO_0031104 | Biological process | dendrite regeneration |
GO_0010594 | Biological process | regulation of endothelial cell migration |
GO_2000036 | Biological process | regulation of stem cell population maintenance |
GO_0042246 | Biological process | tissue regeneration |
GO_0043113 | Biological process | receptor clustering |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0007185 | Biological process | cell surface receptor protein tyrosine phosphatase signaling pathway |
GO_1900006 | Biological process | positive regulation of dendrite development |
GO_0048714 | Biological process | positive regulation of oligodendrocyte differentiation |
GO_0048680 | Biological process | positive regulation of axon regeneration |
GO_0030282 | Biological process | bone mineralization |
GO_0140059 | Biological process | dendrite arborization |
GO_0007613 | Biological process | memory |
GO_1900272 | Biological process | negative regulation of long-term synaptic potentiation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0002232 | Biological process | leukocyte chemotaxis involved in inflammatory response |
GO_0045778 | Biological process | positive regulation of ossification |
GO_2000738 | Biological process | positive regulation of stem cell differentiation |
GO_0030501 | Biological process | positive regulation of bone mineralization |
GO_0048477 | Biological process | oogenesis |
GO_0007399 | Biological process | nervous system development |
GO_0002690 | Biological process | positive regulation of leukocyte chemotaxis |
GO_0007406 | Biological process | negative regulation of neuroblast proliferation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0008201 | Molecular function | heparin binding |
GO_0140677 | Molecular function | molecular function activator activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0005178 | Molecular function | integrin binding |
GO_0004864 | Molecular function | protein phosphatase inhibitor activity |
GO_0035374 | Molecular function | chondroitin sulfate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PTN |
Protein name | Pleiotrophin Pleiotrophin (PTN) (Heparin-binding brain mitogen) (HBBM) (Heparin-binding growth factor 8) (HBGF-8) (Heparin-binding growth-associated molecule) (HB-GAM) (Heparin-binding neurite outgrowth-promoting factor) (HBNF) (Heparin-binding neurite outgrowth-promoting factor 1) (HBNF-1) (Osteoblast-specific factor 1) (OSF-1) |
Synonyms | HBNF1 NEGF1 |
Description | FUNCTION: Secreted growth factor that mediates its signal through cell-surface proteoglycan and non-proteoglycan receptors . Binds cell-surface proteoglycan receptor via their chondroitin sulfate (CS) groups . Thereby regulates many processes like cell proliferation, cell survival, cell growth, cell differentiation and cell migration in several tissues namely neuron and bone . Also plays a role in synaptic plasticity and learning-related behavior by inhibiting long-term synaptic potentiation (By similarity). Binds PTPRZ1, leading to neutralization of the negative charges of the CS chains of PTPRZ1, inducing PTPRZ1 clustering, thereby causing the dimerization and inactivation of its phosphatase activity leading to increased tyrosine phosphorylation of each of the PTPRZ1 substrates like ALK, CTNNB1 or AFAP1L2 in order to activate the PI3K-AKT pathway . Through PTPRZ1 binding controls oligodendrocyte precursor cell differentiation by enhancing the phosphorylation of AFAP1L2 in order to activate the PI3K-AKT pathway . Forms a complex with PTPRZ1 and integrin alpha-V/beta-3 (ITGAV:ITGB3) that stimulates endothelial cell migration through SRC dephosphorylation and activation that consequently leads to ITGB3 'Tyr-773' phosphorylation . In adult hippocampus promotes dendritic arborization, spine development, and functional integration and connectivity of newborn granule neurons through ALK by activating AKT signaling pathway (By similarity). Binds GPC2 and chondroitin sulfate proteoglycans (CSPGs) at the neuron surface, leading to abrogation of binding between PTPRS and CSPGs and neurite outgrowth promotion (By similarity). Binds SDC3 and mediates bone formation by recruiting and attaching osteoblasts/osteoblast precursors to the sites for new bone deposition (By similarity). Binds ALK and promotes cell survival and cell proliferation through MAPK pathway activation . Inhibits proliferation and enhances differentiation of neural stem cells by inhibiting FGF2-induced fibroblast growth factor receptor signaling pathway (By similarity). Mediates regulatory mechanisms in normal hemostasis and in hematopoietic regeneration and in maintaining the balance of myeloid and lymphoid regeneration (By similarity). In addition may play a role in the female reproductive system, auditory response and the progesterone-induced decidualization pathway (By similarity). . |
Accessions | C9JR52 P21246 ENST00000348225.7 A0A8V8TNI1 ENST00000393083.2 ENST00000699293.1 |